AI Summary

Bacteria have spent decades evolving resistance to virtually every antibiotic we have thrown at them. To stay ahead, new drugs must hit targets that existing antibiotics have never touched. A research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has now developed a series of synthetic drug candidates that do exactly that: By blocking an essential molecular supply system, these molecules cut off the bacteria's supply of essential vitamins and starve them to death. The team published its findings in two studies in the Journal of Medicinal Chemistry.

AI summaries can be wrong sometimes—always verify important details using the source article.